Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
Saved in:
| Title: | Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial. |
|---|---|
| Authors: | Berger JS; NYU Grossman School of Medicine, New York, New York., Kornblith LZ; University of California, San Francisco., Gong MN; Albert Einstein College of Medicine, Bronx, New York., Reynolds HR; NYU Grossman School of Medicine, New York, New York., Cushman M; College of Medicine, University of Vermont, Burlington., Cheng Y; University of Pittsburgh, Pittsburgh, Pennsylvania., McVerry BJ; University of Pittsburgh, Pittsburgh, Pennsylvania., Kim KS; University of Illinois, Chicago., Lopes RD; Duke University Medical Center, Durham, North Carolina., Atassi B; OSF Little Company of Mary Medical Center, Evergreen Park, Illinois., Berry S; Berry Consultants LLC, Austin, Texas., Bochicchio G; School of Medicine, Washington University, St Louis, Missouri., de Oliveira Antunes M; Hospital Universitario São Francisco de Assis, São Paulo, Brazil., Farkouh ME; Peter Munk Cardiac Centre, Toronto, Ontario, Canada., Greenstein Y; New Jersey Medical School, Rutgers University, Newark., Hade EM; NYU Grossman School of Medicine, New York, New York., Hudock K; University of Cincinnati Medical Center, Cincinnati, Ohio., Hyzy R; University of Michigan, Ann Arbor., Khatri P; University of Cincinnati Medical Center, Cincinnati, Ohio., Kindzelski A; National Heart, Lung, and Blood Institute, Bethesda, Maryland., Kirwan BA; Socar Research SA, Nyon, Switzerland., Baumann Kreuziger L; Versity Blood Research Institute, Milwaukee, Wisconsin., Lawler PR; Peter Munk Cardiac Centre, Toronto, Ontario, Canada., Leifer E; National Heart, Lung, and Blood Institute, Bethesda, Maryland., Lopez-Sendon Moreno J; Hospital Universitario Ramon Y Cajal, Madrid, Spain., Lopez-Sendon J; Hospital Universitario La Paz, Madrid, Spain., Luther JF; University of Pittsburgh, Pittsburgh, Pennsylvania., Nigro Maia L; Fundação Faculdade Regional De Medicina De São José Do Rio Preto, São José do Rio Preto, Brazil., Quigley J; University of Illinois, Chicago., Sherwin R; Wayne State University, Detroit, Michigan., Wahid L; Duke University Hospital, Durham, North Carolina., Wilson J; Stanford University Medical Center, Stanford, California., Hochman JS; NYU Grossman School of Medicine, New York, New York., Neal MD; University of Pittsburgh, Pittsburgh, Pennsylvania. |
| Corporate Authors: | ACTIV-4a Investigators |
| Source: | JAMA [JAMA] 2022 Jan 18; Vol. 327 (3), pp. 227-236. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1538-3598 |
|---|---|
| DOI: | 10.1001/jama.2021.23605 |
